Reinventing Your Supply Chain

News

Press Release:
August 2016

Aphena Relocates and Expands Chocolated Manufacturing Operations

Improvements Create Fourfold Increase in Production Capacity

TREVOSE, Pennsylvania — Aphena Pharma Solutions is pleased to announce the relocation and major expansion of our chocolated pharmaceutical manufacturing operations.

Offerings include brand-equivalent formulations of senna OTC laxatives (compare to Ex-Lax ®) marketed as private-label products. All production has been transferred out of our previous site in Sherburne, New York, to new production suites at Aphena's FDA-registered, cGMP facility in Easton, Maryland, where we have on-site analytical and microbiological laboratories that support the production operation.

At Easton, we have implemented several improvements to significantly increase capacity and throughput of the manufacturing and packaging operations via debottlenecking. Also, several process modifications have been implemented for a more continuous and highly efficient production operation. These improvements provide for up to a fourfold annual capacity increase, and additional space at the facility is available for further expansion.

Aphena has continued to develop new, improved laxative formulas to meet consumer preferences, and we actively assist customers with process development and scale-up services for new chocolate-based nutritional supplement formulas as well as for pharmaceuticals in other therapeutic categories.

The only U.S. contract manufacturer of chocolate-based pharmaceuticals, Aphena provides a full range of solid and semisolid packaging solutions. Call us at 866-465-4506 to find out more about what Aphena can do for you!

Click here for more information, or call us at 1-866-465-4506.

   
 
Corporate Office: 1-866-465-4506